HIGHFDA DRUG

Rising Pharmaceuticals Recalls Furosemide Tablets for Contamination Risk

Rising Pharmaceuticals recalled 4,212 bottles of Furosemide Tablets on January 10, 2026. The recall stems from the discovery of a foreign substance in the medication. Consumers should stop using the product immediately and seek guidance from their healthcare provider.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
January 10, 2026
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
January 10, 2026
Hazard Level
HIGH
Brands
FUROSEMIDE, Rising Pharma Holdings, Inc.
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
FUROSEMIDE, Rising Pharma Holdings, Inc.
Product type
Furosemide Tablets
Model numbers
Lot# FUB125042G, Exp. 05/13/2027
UPC codes
64980-562, 64980-563, 64980-564, 64980-562-01, 64980-562-10, 64980-563-01, 64980-563-10, 64980-564-01 +1 more
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    January 10, 2026

  2. Reported by FDA DRUG

    January 28, 2026

  3. RecallRadar source check

    February 4, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Presence of Foreign Substance

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Graviti Pharmaceuticals Private Limited or your healthcare provider for guidance. Notification method: Letter

About This Product

Furosemide Tablets are a prescription medication used to treat fluid retention and swelling caused by heart failure or other medical conditions. Consumers buy this medication to manage their health effectively under their healthcare provider's guidance.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

The recall requires immediate action from consumers, potentially disrupting their medication routines and necessitating alternative treatment plans.

Practical Guidance

How to identify if yours is affected

  1. Locate the lot number on your Furosemide Tablets bottle.
  2. Check if it matches the recalled lot number FUB125042G.
  3. Verify the expiration date, which should be May 13, 2027.

Where to find product info

The lot number and expiration date can usually be found on the label of the bottle or on the bottom of the packaging.

What timeline to expect

Expect a refund or replacement process to take approximately 4-6 weeks.

If the manufacturer is unresponsive

  • Document all communication attempts with the company.
  • Consider filing a complaint with the FDA if there is no response.

How to prevent similar issues

  • Always check for recalls on medications before use.
  • Consult with your healthcare provider about any concerns regarding your medications.

Documentation advice

Keep records of your purchase, including receipts and any correspondence regarding the recall.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The recall affects Furosemide Tablets, USP 40 mg, sold in 1,000-tablet bottles. The affected lot number is FUB125042G with an expiration date of May 13, 2027. These products were distributed nationwide in the U.S.

Key Facts

  • Recalled product: Furosemide Tablets, USP 40 mg
  • Total units recalled: 4,212 bottles
  • Recall date: January 10, 2026
  • Expiration date: May 13, 2027
  • Manufactured by: Graviti Pharmaceuticals Pvt. Ltd.

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot# FUB125042G
Exp. 05/13/2027
UPC Codes
64980-562
64980-563
64980-564
+6 more
Affected States
ALL
Report Date
January 28, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls